The Hippo Show Must Go On: YAP Activation as a Therapeutic Strategy in Colorectal Cancer.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 33007230.
- Also identified by DOI 10.1016/j.stem.2020.09.007.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The role of Hippo pathway in colorectal cancer (CRC) initiation and progression has been controversial. In this issue of Cell Stem Cell, Cheung et al. (2020) shed new light on a distinct function of the transcriptional co-activator YAP as a tumor suppressor and Wnt pathway inhibitor in CRC.
Medical subject headings
- Colorectal Neoplasms
- Protein Serine-Threonine Kinases